Literature DB >> 26199348

Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study.

Stefan Presslauer1, Dejan Milosavljevic2, Wolfgang Huebl3, Fahmy Aboulenein-Djamshidian4, Walter Krugluger5, Florian Deisenhammer6, Makbule Senel7, Hayrettin Tumani7, Harald Hegen8.   

Abstract

BACKGROUND: Kappa free light chains (KFLCs) have been proposed as a diagnostic biomarker in patients with clinically isolated syndrome (CIS) and multiple sclerosis (MS).
OBJECTIVE: The objective of this paper is to validate the diagnostic accuracy of intrathecal KFLC synthesis in a multicenter study.
METHODS: KFLCs were measured by nephelometry under blinded conditions in cerebrospinal fluid (CSF) and serum sample pairs of patients with CIS (n = 60), MS (n = 60) and other neurological diseases (n = 60) from four different MS centers. The upper normal limit for intrathecal KFLC concentrations depending on blood-CSF barrier function was previously calculated in a cohort of 420 control patients.
RESULTS: Diagnostic sensitivity of intrathecal KFLC synthesis, IgG synthesis according to Reiber, IgG index and oligoclonal bands (OCBs) was 95%, 72%, 73% and 93% in patients with MS and 82%, 47%, 43% and 72% in patients with CIS. Specificity of intrathecal KFLC synthesis was 95% and 98% for all other measures.
CONCLUSION: These findings further support the diagnostic value of intrathecal KFLC synthesis in CIS and MS patients and demonstrate a valid, easier and rater-independent alternative to OCB detection.
© The Author(s), 2015.

Entities:  

Keywords:  IgG index; Kappa free light chain; cerebrospinal fluid; clinically isolated syndrome; intrathecal IgG synthesis; multiple sclerosis; oligoclonal bands; serum

Mesh:

Substances:

Year:  2015        PMID: 26199348     DOI: 10.1177/1352458515594044

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  20 in total

Review 1.  [Cerebrospinal fluid diagnostics in multiple sclerosis].

Authors:  K Ruprecht; H Tumani
Journal:  Nervenarzt       Date:  2016-12       Impact factor: 1.214

2.  Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis-from diagnosis to prediction of disease activity.

Authors:  Harald Hegen; Klaus Berek; Florian Deisenhammer
Journal:  Wien Med Wochenschr       Date:  2022-02-08

Review 3.  Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases.

Authors:  Julia Doroszkiewicz; Magdalena Groblewska; Barbara Mroczko
Journal:  Int J Mol Sci       Date:  2022-04-21       Impact factor: 6.208

4.  Immunoglobulin free light chains in saliva: a potential marker for disease activity in multiple sclerosis.

Authors:  B Kaplan; S Golderman; E Ganelin-Cohen; A Miniovitch; E Korf; I Ben-Zvi; A Livneh; S Flechter
Journal:  Clin Exp Immunol       Date:  2017-12-26       Impact factor: 4.330

5.  Validation of CSF free light chain in diagnosis and prognosis of multiple sclerosis and clinically isolated syndrome: prospective cohort study in Buenos Aires.

Authors:  María Soledad Sáez; Juan Ignacio Rojas; María Victoria Lorenzón; Francisco Sánchez; Liliana Patrucco; Jimena Míguez; Carolina Azcona; Patricia Sorroche; Edgardo Cristiano
Journal:  J Neurol       Date:  2018-11-01       Impact factor: 4.849

6.  Assessment of Intrathecal Free Light Chain Synthesis: Comparison of Different Quantitative Methods with the Detection of Oligoclonal Free Light Chains by Isoelectric Focusing and Affinity-Mediated Immunoblotting.

Authors:  David Zeman; Pavlína Kušnierová; Zdeněk Švagera; František Všianský; Monika Byrtusová; Pavel Hradílek; Barbora Kurková; Olga Zapletalová; Vladimír Bartoš
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

7.  Free Light Chains and Intrathecal B Cells Activity in Multiple Sclerosis: A Prospective Study and Meta-Analysis.

Authors:  Gabriella Passerini; Gloria Dalla Costa; Francesca Sangalli; Lucia Moiola; Bruno Colombo; Massimo Locatelli; Giancarlo Comi; Roberto Furlan; Vittorio Martinelli
Journal:  Mult Scler Int       Date:  2016-12-28

Review 8.  Multiple sclerosis: an example of pathogenic viral interaction?

Authors:  Walter Fierz
Journal:  Virol J       Date:  2017-02-28       Impact factor: 4.099

9.  Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.

Authors:  C E Leurs; Ham Twaalfhoven; B I Lissenberg-Witte; V van Pesch; I Dujmovic; J Drulovic; M Castellazzi; T Bellini; M Pugliatti; J Kuhle; L M Villar; J C Alvarez-Cermeño; R Alvarez-Lafuente; H Hegen; F Deisenhammer; L M Walchhofer; E Thouvenot; M Comabella; X Montalban; L Vécsei; C Rajda; D Galimberti; E Scarpini; A Altintas; K Rejdak; J L Frederiksen; G Pihl-Jensen; Peh Jensen; M Khalil; M M Voortman; F Fazekas; A Saiz; D La Puma; M Vercammen; L Vanopdenbosch; Bmj Uitdehaag; J Killestein; C Bridel; C Teunissen
Journal:  Mult Scler       Date:  2019-05-08       Impact factor: 6.312

10.  Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease Activity.

Authors:  Klaus Berek; Gabriel Bsteh; Michael Auer; Franziska Di Pauli; Astrid Grams; Dejan Milosavljevic; Paulina Poskaite; Christine Schnabl; Sebastian Wurth; Anne Zinganell; Thomas Berger; Janette Walde; Florian Deisenhammer; Harald Hegen
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.